
Tsumura & Co.
TSMRF
Updated: 23/09/2026, 23:04:28
Tsumura & Co. is a global pharmaceutical company specializing in the production and distribution of various medicinal products. Their core offerings include Kampo extract intermediates and granular Kampo formulations. The company manages the comprehensive process of bringing these traditional remedies to market, from the sourcing, meticulous selection, and processing of raw herbal ingredients to their careful warehousing, including components prepared for traditional decoctions. Tsumura & Co. also manufactures powdered Kampo extracts and a range of traditional Chinese medical preparations. Beyond pharmaceuticals, the company additionally distributes food items. Established in 1893, Tsumura & Co. maintains its headquarters in Tokyo, Japan.
No summaries found.
- Share price
- $23.20
- Market cap
- $1.73B
- Exchange
- OTC
- Currency
- USD
- CEO
- Terukazu Kato
- Employees
- 4,923
- IPO date
- 22/02/2013
- Beta
- 0.068
- Last dividend
- $0.00
- Day range
- $23.20 – $28.15
- 52-week range
- $23.20 – $28.15
- 1-day performance
- 0.00%
- 1-year performance
- 0.00%
- Current drawdown (1Y)
- -17.58%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- JP3535800001
- Created
- 07/12/2025, 14:48:28
- Last update
- 23/09/2026, 23:04:28
Track Tsumura & Co. with an AI analyst
See which prediction-market events move TSMRF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.